U.S. federal trademark · Serial No. 75310675
consulting services, namely, developing therapeutic strategies using pharmaceutical and drugs for others
pharmaceuticals, namely, nitric oxide synthase inhibitors for the treatment of emesis, nausea, anxiety and schizophrenia
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.